z-logo
open-access-imgOpen Access
Tofacitinib Citrate for the Treatment of Vitiligo
Author(s) -
Brittany G. Craiglow,
Brett King
Publication year - 2015
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2015.1520
Subject(s) - vitiligo , tofacitinib , medicine , janus kinase , janus kinase inhibitor , dermatology , immunology , rheumatoid arthritis , cytokine
Vitiligo is a common condition that is often emotionally devastating for patients. At present, no reliably effective treatments are available.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom